Probiotics vs Antibiotics as an add-on to non-surgical periodontal care in adult smokers with stage II, grade B periodontitis
Official title: Clinical and Biochemical Evaluation of Probiotics Versus Antibiotics as an Adjuvant to Non-surgical Periodontal Treatment Among Smokers With Stage II, Grade B Periodontitis
Run by October 6 University · NCT07923695 · Data updated 2026-11-12
This study tests whether systemic probiotics or systemic antibiotics added to standard non-surgical periodontal treatment help improve gum health in adult smokers with stage II, grade B periodontitis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 50 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | October 6 University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | September 1, 2024 |
| Main results expected | June 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07923695 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 25-50 who are current or former smokers with stage II, grade B periodontitis and clinical attachment loss of 3–4 mm.
✕Probably not a fit
Patients with systemic diseases affecting periodontal health or recent periodontal therapy or antibiotic/probiotic use may not benefit or could be excluded from potential benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial compares two systemic add-ons—probiotics and antibiotics—used with scaling and root planing in adult smokers diagnosed with stage II, grade B periodontitis. Outcomes include clinical measures of periodontal health and biochemical markers in gingival crevicular fluid, such as inflammatory mediators. The study aims to see if probiotics can offer similar or superior benefits to antibiotics by restoring microbial balance and modulating inflammation. Participants are adults aged 25-50 with specified disease characteristics, and the treatment is delivered in an institutional setting in Cairo. The trial reflects an interest in adjuvant therapies that may reduce tissue destruction while promoting periodontal stability.
Why it matters
Potential benefit: If successful, patients could gain improved periodontal health and reduced inflammatory activity when probiotics are used as an adjunct to standard care.
How similar studies have gone: Previous work suggests probiotics can modulate inflammation in periodontal disease, though results vary and this direct head-to-head comparison with antibiotics is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 25-50 years * Periodontitis male patients diagnosed as they having Stage II, Grade B periodontitis * Clinical attachment loss 3-4 mm * Radiographic bone loss in coronal third. * Current smokers or non-smokers. Exclusion Criteria: * Systemic diseases affecting periodontal health. * Periodontal therapy within last 6 months. * Use of antibiotics, probiotics or anti-inflammatory medication within last 3 months. * History of allergy to the prescribed study medications. * Patients unwilling to comply with study instructions or follow-up visits
Where it's running
-
October 6 University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Ahlam A Al-shawafi, B.Sc
- Email: Periodentistahlam@gmail.com
- Phone: 00201156330099
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ozone Gel vs Chlorhexidine Gel as an add-on to non-surgical cleaning for smokers with Stage II periodontitis
This study tests whether Ozoral ozone gel or chlorhexidine gel added to standard non-surgical periodontal therapy can improve outcomes in smokers with Stage II Grade B periodontitis.
-
Adjuncts to non-surgical periodontal treatment in smokers and non-smokers with periodontitis
This trial tests whether adding I-PRF, povidone-iodine, or diode laser to standard deep cleaning helps reduce pocket depth and improve gum health in adults with periodontitis, including smokers.
-
Lovastatin gel under the gum plus deep cleaning for periodontitis in smokers and non-smokers
This test sees if placing a 1.2% lovastatin gel under the gum after deep cleaning helps adults with periodontitis, comparing smokers and non-smokers.
-
Antibiotics versus no antibiotics for flexible ureteroscopy with a negative-pressure suction sheath
This trial will test whether adults at low risk of infection having single-use flexible ureteroscopy with a negative-pressure suction sheath can safely skip the usual single-dose antibiotic before surgery.
-
Clostridium butyricum for anxiety and depression in functional dyspepsia
This trial will test whether taking the probiotic Clostridium butyricum for four weeks can reduce anxiety and depression symptoms in adults with functional dyspepsia.
-
Oral Clostridium butyricum to prevent colorectal adenoma recurrence after removal
This study tests whether a probiotic capsule containing Clostridium butyricum can reduce the chance of colorectal adenomas coming back after they are removed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.